Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care

被引:18
作者
Krueger, Karen [1 ,2 ,3 ]
Leppkes, Niklas [2 ,3 ,4 ]
Gehrke-Beck, Sabine [1 ,2 ,3 ]
Herrmann, Wolfram [1 ,2 ,3 ]
Algharably, Engi A. [2 ,3 ,5 ]
Kreutz, Reinhold [2 ,3 ,4 ]
Heintze, Christoph [1 ,2 ,3 ]
Filler, Iris [2 ,3 ,4 ]
机构
[1] Charite Univ Med Berlin, Inst Gen Practice, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin Inst Hlth, Berlin, Germany
[4] Charite Univ Med Berlin, Inst Clin Pharmacol & Toxicol, Berlin, Germany
[5] Ain Shams Univ, Fac Pharm, Dept Clin Pharm, Cairo, Egypt
关键词
general practice; medication adherence; primary health care; qualitative research; statins; RISK; DISCONTINUATION; NONADHERENCE; PREVENTION; PREDICTORS; MANAGEMENT; PATIENT;
D O I
10.3399/bjgp18X696173
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Statins substantially reduce the risk of cardiovascular disease when taken regularly. Though statins are generally well tolerated, current studies show that one-third of patients discontinue use of statins within 2 years. A qualitative approach may improve the understanding of attitudes and behaviours towards statins, the mechanisms related to discontinuation, and how they are managed in primary care. Aim To identify factors related to statin discontinuation and approaches for long-term statin adherence. Design and setting A qualitative study of German GPs' experiences with statin therapy in rural and urban settings in primary care. Method Semi-structured interviews (n = 16) with purposefully recruited GPs were recorded, transcribed, and analysed using qualitative content analysis. Results Sociodemographic patient factors, the nocebo effect, patient attitudes towards primary prevention, and negative media coverage had significant impacts on statin therapy according to GPs. To overcome these barriers, GPs described useful strategies combining patient motivation and education with person-centred care. GPs used computer programs for individual risk-benefit analyses in the context of shared decision making. They encouraged patients with strong concerns or perceived side effects to continue therapy with a modified medication regimen combined with individual therapy goals. Conclusion GPs should be aware of barriers to statin therapy and useful approaches to overcome them. They could be supported by guideline recommendations that are more closely aligned to primary care as well as comprehensible patient information about lipid-lowering therapy. Future studies, exploring patients' specific needs and involving them in improving adherence behaviour, are recommended.
引用
收藏
页码:E401 / E407
页数:7
相关论文
共 40 条
[1]   Suboptimal use of statin therapy in elderly patients with atherosclerosis: A population-based study [J].
Al-Omran, Mohammed ;
Mamdani, Muhammad M. ;
Lindsay, Thomas F. ;
Melo, Magda ;
Juurlink, David N. ;
Verma, Subodh .
JOURNAL OF VASCULAR SURGERY, 2008, 48 (03) :607-612
[2]   Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study [J].
Assmann, G ;
Cullen, P ;
Schulte, H .
CIRCULATION, 2002, 105 (03) :310-315
[3]  
Aubert RE, 2010, AM J MANAG CARE, V16, P459
[4]   2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J].
Catapano, Alberico L. ;
Graham, Ian ;
De Backer, Guy ;
Wiklund, Olov ;
Chapman, M. John ;
Drexel, Heinz ;
Hoes, Arno W. ;
Jennings, Catriona S. ;
Landmesser, Ulf ;
Pedersen, Terje R. ;
Reiner, Zeljko ;
Riccardi, Gabriele ;
Taskinen, Marja-Riita ;
Tokgozoglu, Lale ;
Verschuren, W. M. Monique ;
Vlachopoulos, Charalambos ;
Wood, David A. ;
Luis Zamorano, Jose .
ATHEROSCLEROSIS, 2016, 253 :281-344
[5]   Persistence of use of lipid-lowering medications - A cross-national study [J].
Avorn, J ;
Monette, J ;
Lacour, A ;
Bohn, RL ;
Monane, M ;
Mogun, H ;
LeLorier, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1458-1462
[6]   Non-adherence to statin therapy: a major challenge for preventive cardiology [J].
Bates, T. R. ;
Connaughton, V. M. ;
Watts, G. F. .
EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (18) :2973-2985
[7]  
Bohan H, 2015, PERCEPTIONS STATINS
[8]   Person-Centered Care: A Definition and Essential Elements [J].
Brummel-Smith, Kenneth ;
Butler, Dawn ;
Frieder, Miryam ;
Gibbs, Nancy ;
Henry, Maureen ;
Koons, Eileen ;
Loggers, Elizabeth ;
Porock, Davina ;
Reuben, David B. ;
Saliba, Debra ;
Scanlon, William J. ;
Tabbush, Victor ;
Tinetti, Mary ;
Tumlinson, Anne ;
Vladeck, Bruce C. ;
Kogan, Alexis Coulourides ;
Mosqueda, Laura ;
Wilber, Kate ;
Goodwin, Carol ;
Lundebjerg, Nancy E. ;
Mikhailovich, Anna ;
Aiello, Susan E. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (01) :15-18
[9]  
Campione Joanne R, 2005, Am J Geriatr Pharmacother, V3, P229, DOI 10.1016/j.amjopharm.2005.12.001
[10]   Patient, Physician, and Payment Predictors of Statin Adherence [J].
Chan, David C. ;
Shrank, William H. ;
Cutler, David ;
Jan, Saira ;
Fischer, Michael A. ;
Liu, Jun ;
Avorn, Jerry ;
Solomon, Daniel ;
Brookhart, Alan ;
Choudhry, Niteesh K. .
MEDICAL CARE, 2010, 48 (03) :196-202